How RWE can help Biotechs optimize the value of their asset
Traditionally, real-world data (RWD) and real-world evidence (RWE) have not been viewed as critical components to be incorporated into the drug development journey to demonstrate value for market access and product launch/commercialization. With the majority of small and emerging biotech companies choosing to seek out partnership or licensing deals to support pivotal trials and ultimately commercialization of their asset, there was little exposure to the numerous benefits RWD and RWE can provide to these companies early in their development planning and execution.
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Guide for Real-World Evidence
May 21, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Guide for Real-World Evidence
May 21, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022